Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,351,851
+$345,268 QoQ
Shares Held
56,140
+56.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,148
of 2,828 holders
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026T. Rowe Price Investment Management, Inc. holds $130,347,685 across 8 Drug Manufacturers - General names. PFE ranks #7 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
50,482 | $60,549,630 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
276,379 | $34,917,722 | |
| 3 | BIIB |
Biogen Inc.
|
113,873 | $24,603,400 | |
| 4 | JNJ |
Johnson & Johnson
|
19,637 | $4,987,208 | |
| 5 | ABBV |
AbbVie Inc.
|
5,805 | $1,460,770 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
24,400 | $1,405,928 | |
| 7 | PFE |
Pfizer Inc
This page
|
56,140 | $1,351,851 | |
| 8 | MRK |
Merck & Co., Inc.
|
8,336 | $1,071,176 |
All Filings in PFE
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,351,851 | 56,140 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,006,583 | 35,847 | Shares | Sole | 2026-05-15 | |
| 2025-06-30 | $32,820 | 1,354 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||